Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Eukaryotic translation elongation factor 1 alpha 1 pseudogene 1 (EEF1A1P1) is a processed pseudogene derived from the EEF1A1 gene, which encodes a key translation elongation factor involved in the delivery of aminoacyl-tRNAs to the ribosome during protein synthesis[2][4]. EEF1A1P1 itself does not encode a functional protein and is considered a non-coding genomic element. While the parent gene EEF1A1 has a critical role in cellular biology and disease, including cancer, pseudogenes like EEF1A1P1 have not established direct molecular or disease functions and are not therapeutic targets[4]. The human genome contains a large number of EEF1A1-related pseudogenes, often classified as "retropseudogenes." Most are uncharacterized and lack experimental evidence of function[4]. Pseudogenes can occasionally exert regulatory effects (e.g., via RNA interference or as microRNA decoys), but there is no evidence that EEF1A1P1 has such activity[4]. Only the EEF1A1 gene itself (not the pseudogene) is studied extensively in protein synthesis, stress responses, and diseases[1][3][5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Eukaryotic translation elongation factor 1 alpha 1 pseudogene 1 (EEF1A1P1).